Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21103460 | 0.81 | GAA (0.32) | GAA | |
| SCHEMBL21102845 | 0.81 | GAA (0.32) | L3MBTL1GAATSHR | |
| SCHEMBL17931210 | 0.81 | GAA (0.32) | GAA | |
| SCHEMBL21102786 | 0.79 | GAA (0.37) | GAA | |
| SCHEMBL3160904 | 0.79 | LMNA (0.37) | KMT2AMEN1POLBCYP3A4MAPT | |
| SCHEMBL21102857 | 0.79 | GAA (0.37) | GAA | |
| SCHEMBL17931820 | 0.79 | MAPK1 (0.35) | KMT2AMEN1GAA | |
| SCHEMBL21102858 | 0.79 | GAA (0.34) | GAA | |
| SCHEMBL21102676 | 0.79 | SMN1; SMN2 (0.33) | ATML3MBTL1KMT2AMEN1PKM | |
| SCHEMBL21102488 | 0.78 | NAAA (0.32) | ATML3MBTL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731607-A1 | PIPERIDINE, PYRROLIDINE AND ISOINDOLE PRECURSORS OF PROBES FOR OXIDATIVE STRESS | Centre National de la Recherche Scientifique (FR) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024261041-A1 | PIPERIDINE, PYRROLIDINE AND ISOINDOLE PRECURSORS OF PROBES FOR OXIDATIVE STRESS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-12-26 | — | — | WO | disclosed |
| US-10633590-B2 | Liquid crystal composition and liquid crystal display device including the same | DIC CORPORATION (JP) | 2020-04-28 | — | — | US | disclosed |
| US-10329252-B2 | Stabilizer compound, liquid crystal composition, and display element | DIC CORPORATION (JP) | 2019-06-25 | — | — | US | disclosed |
| CN-101223172-B | substituted Rylene derivatives | BASF AG (DE) | 2015-11-25 | — | — | CN | disclosed |
| WO-2015032951-A1 | A PROCESS FOR THE PREPARATION OF A CONDUCTIVE POLYMER COMPOSITE | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2015-03-12 | — | — | WO | disclosed |
| US-8071775-B2 | photovoltaics; emitters in chemiluminescence applications; field-effect transistors and electrophotography; N,N'-Bis(2,6-diisopropylphenyl)-1,7- and -1,6-bis(2,6-diisopropylphenoxy)-perylene-3,4:9,10-tetracarboximide | BASF AKTIENGESELLSCHAFT (DE) | 2011-12-06 | — | — | US | disclosed |
| US-20100011656-A1 | USE OF RYLENES AS MARKERS FOR LIQUIDS | BASF SE (DE) | 2010-01-21 | — | — | US | disclosed |
| US-20090124732-A1 | Rylene Tetracarboxylic Acid Diimides Substituted By Cyclic Amino Groups | BASF AKTIENGESELLSCHAFT (DE) | 2009-05-14 | — | — | US | disclosed |
| CN-101389737-A | Use of polynuclear phenolic compounds as stabilisers | BASF SE (DE) | 2009-03-18 | — | — | CN | disclosed |
| CN-101223172-A | Substituted rylene derivatives | BASF SE (DE) | 2008-07-16 | — | — | CN | disclosed |
| US-20080167467-A1 | Substituted Rylene Derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-10 | — | — | US | disclosed |
| US-4925652-A | NUCLEAR MAGNETIC RESONANCE | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-05-15 | — | — | US | disclosed |
| US-4845090-A | NUCLEAR MAGNETIC RESONANCE | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167467-A1 | Substituted Rylene Derivatives | NR3C2, NR2C2, NR2E3 | ATM 4567/4885L3MBTL1 3674/4885KMT2A 2472/4885 |
| US-20090124732-A1 | Rylene Tetracarboxylic Acid Diimides Substituted By Cyclic Amino Groups | NR1I3, NR1I2, NR1H3 | ATM 4055/4885L3MBTL1 2214/4885KMT2A 1168/4885 |
| US-10329252-B2 | Stabilizer compound, liquid crystal composition, and display element | VSIR, BAG6, HEATR1 | ATM 3948/4885L3MBTL1 591/4885KMT2A 4570/4885 |
| US-10633590-B2 | Liquid crystal composition and liquid crystal display device including the same | LASP1, UACA, CCDC22 | ATM 865/4885L3MBTL1 1932/4885KMT2A 4013/4885 |
| US-20100011656-A1 | USE OF RYLENES AS MARKERS FOR LIQUIDS | RPL22, PROX1, RPL29 | ATM 2975/4885L3MBTL1 1394/4885KMT2A 2164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.